Fondation Ophtalmologique Adolphe de Rothschild
for.parisTotal trials
312
Active
82
Phase 3
11
Total enrollment
54,416
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 13 of 13 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Bevacizumab | — | — | — | — | — | 1 | |
| glenzocimab | — | — | — | — | — | 1 | |
| Cangrelor | — | — | — | — | — | 1 | |
| Ocrelizumab Injection [Ocrevus] | — | — | — | — | — | 1 | |
| immediate treatment with corticosteroids | — | — | — | — | — | 1 | |
| addition of rituximab if recurrence | — | — | — | — | — | 1 | |
| Probenecid | — | — | — | — | — | 1 | |
| Subconjunctival injection of 1 mL with 5 million allogeneic BM-MSCs; one repeat within 21 days. | — | — | — | — | — | 1 | |
| Daily infusion of dornase alfa | — | — | — | — | — | 1 | |
| etanercept and repeated contrast ultrasound | — | — | — | — | — | 1 | |
| blood sample | — | — | — | — | — | 2 | |
| Atropine 0.05% eyedrops | — | — | — | — | — | 1 | |
| Sampling of blood, frozen resected tissues, and cerebrospinal fluid | — | — | — | — | — | 1 |
Next readouts
- 2026-02
- 2026-03
- 2026-12
- 2027-02-21
- 2028-01-15
- 2028-03
- 2028-06
- 2028-06
- 2029-02
- 2029-09
Top conditions
- Multiple Sclerosis15
- Epilepsy9
- Optic Neuritis7
- Cataract7
- Stroke7
- Ischemic Stroke7
- Myopia5
- Magnetic Resonance Imaging5
Frequently asked questions about Fondation Ophtalmologique Adolphe de Rothschild
- How many clinical trials does Fondation Ophtalmologique Adolphe de Rothschild have on ClinicalTrials.gov?
- Fondation Ophtalmologique Adolphe de Rothschild is listed as the lead sponsor on 312 clinical trials in ClinicalTrials.gov, 82 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Fondation Ophtalmologique Adolphe de Rothschild's trials are in Phase 3?
- 11 of Fondation Ophtalmologique Adolphe de Rothschild's trials are in Phase 3, spread across 13 active drug programs.
- What therapeutic areas does Fondation Ophtalmologique Adolphe de Rothschild focus on?
- Fondation Ophtalmologique Adolphe de Rothschild's most-studied conditions on ClinicalTrials.gov are Multiple Sclerosis, Epilepsy, Optic Neuritis, Cataract, Stroke.
- When are Fondation Ophtalmologique Adolphe de Rothschild's next clinical trial readouts?
- Fondation Ophtalmologique Adolphe de Rothschild has 10 upcoming primary-completion readouts tracked here; the soonest is “Myopia Control in Children: Comparison of Defocus Incorporated Multiple Segments® Lenses Versus Atropine 0.05% Eyedrops”, expected around 2026-02.